Periodic Reporting for period 3 - CLINGLIO (A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.)

The CLINGLIO project addresses the clinical unmet need of patients bearing glioma through the advance of novel therapeutic strategies. This project involves a high level of social impact since glioma is the most common brain cancer in adults, representing about 50% of all...